Upholding science in health, safety and environmental risk assessments and regulations.

[1]  C. Demuth.  Can the Administrative State be Tamed , 2016 .

[2]  Philip A. Hamburger.  Is Administrative Law Unlawful , 2014 .

[3]  D. Shibata.  Heterogeneity and Tumor History , 2012, Science.

[4]  S. Cohen.  Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays , 2010, Toxicologic pathology.

[5]  C. Berry.  Relativism, regulation and the dangers of indifferent science: the Sir Roy Cameron lecture of the Royal College of Pathologists. , 2010, Toxicology.

[6]  L. Werkö.  The enigma of coronary heart disease and its prevention. , 2009, Acta medica Scandinavica.

[7]  Alan R. Boobis,et al.  IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans , 2008, Critical reviews in toxicology.

[8]  Carolyn Vickers,et al.  IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .

[9]  B. McCullough,et al.  Measurement Theory and Practice: The World Through Quantification , 2005 .

[10]  Samuel M Cohen,et al.  Human carcinogenic risk evaluation: an alternative approach to the two-year rodent bioassay. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  R. Kroes.  Structure-Based Thresholds of Toxicological Concern (TTC): Guidance for Application to Substances Present at Low Levels in the Diet , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[12]  Hugh G. Gauch,et al.  Scientific method in practice , 2002 .

[13]  G. Taubes.  The Soft Science of Dietary Fat , 2001, Science.

[14]  J. Cutler,et al.  Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups , 1997 .

[15]  M. Feinleib.  New directions for community intervention studies. , 1996, American journal of public health.

[16]  G. B. Gori.  Science, imaginable risks, and public policy: anatomy of a mirage. , 1996, Regulatory toxicology and pharmacology : RTP.

[17]  V. Salomaa,et al.  Mortality in participants and non-participants of a multifactorial prevention study of cardiovascular diseases: a 28 year follow up of the Helsinki Businessmen Study. , 1995, British heart journal.

[18]  G. Taubes.  Epidemiology faces its limits. , 1995, Science.

[19]  A. Folsom,et al.  Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. , 1994, American journal of public health.

[20]  R. Tennant,et al.  Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. , 1991, Mutation research.

[21]  V. Beral,et al.  UICC workshop on evaluating interventions to reduce cancer risk. Meeting held at Reykjavik, Iceland, September 21–24, 1988 , 1989 .

[22]  Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial. , 1996, Circulation.

[23]  M. Pike,et al.  Some tautologous aspects of the comparison of carcinogenic potency in rats and mice. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[24]  F. D. Di Carlo.  Carcinogenesis bioassay data: correlation by species and sex. , 1984, Drug metabolism reviews.

[25]  J. Huff,et al.  Results from 86 two-year carcinogenicity studies conducted by the National Toxicology Program. , 1984, Journal of toxicology and environmental health.

[26]  J. Huff,et al.  An evaluation of chemicals and industrial processes associated with cancer in humans based on human and animal data: IARC Monographs Volumes 1 to 20. , 1980, Cancer research.

[27]  R A Ford,et al.  Estimation of toxic hazard--a decision tree approach. , 1978, Food and cosmetics toxicology.

[28]  T. Nash.  Chemical Carcinogenesis , 1957, Nature.